GE HealthCare (NASDAQ: GEHC) reported Q4 EPS of $1.44, $0.04 better than the analyst estimate of $1.40. Revenue for the quarter came in at $5.7 million versus the consensus estimate of $5.6 million.

Today, the Company introduces 2026 full-year guidance metrics as follows:

Organic revenue growth* of 3.0% to 4.0% year-over-year
Adjusted EBIT margin* of 15.8% to 16.1%, reflecting an expansion of 50 bps to 80 bps year-over-year
Adjusted effective tax rate (ETR)* in the range of 20.0% to 21.0%
Adjusted EPS* in the range of $4.95 to $5.15, representing 7.9% to 12.3% growth year-over-year
Free cash flow* of approximately $1.7 billion
Expect 2026 tariff impact to be lower than 2025, based on current rates

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.